Author

Apostolos Galaris

Alexander Fleming Biomedical Sciences Research CenterORCID 0000-0002-7367-7675Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Argyrios TzouvelekisiD· 1 shared Bruno CrestaniiD· 1 shared Dimitris Nastos· 1 shared Dionysiοs FanidisiD· 1 shared Eleftheria-Dimitra Ntouskou· 1 shared Eliza TsitouraiD· 1 shared Ilianna Barbayianni· 1 shared Katerina M. AntoniouiD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Argyrios TzouvelekisORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

SRC-mediated and TKS5-enabled podosome formation is an inherent property of IPF fibroblasts, promoting ECM invasion and pulmonary fibrosis

Ilianna Barbayianni, Paraskevi Kanellopoulou, Dionysiοs Fanidis, Eleftheria-Dimitra Ntouskou, Dimitris Nastos, Apostolos Galaris, Vaggelis Harokopos, Pantelis Hatzis, Eliza Tsitoura, Robert Homer, Naftali Kaminski, Katerina M. Antoniou, Bruno Crestani, Argyrios Tzouvelekis, Vassilis Aidinis

This study identifies TKS5-mediated podosome formation in IPF fibroblasts as a driver of ECM invasion and pulmonary fibrosis, with potential therapeutic targeting via src kinase inhibition.

bioRxiv · Jan 25, 2023 · PreprintMolecular Biology

Apostolos Galaris · henhao